ArticlePharmaceutics2022
Exploiting the DNA Damaging Activity of Liposomal Low Dose Cytarabine for Cancer Immunotherapy.
Jordan D Lewicky et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticlePharmaceutics2022
Jordan D Lewicky et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.